Silicon Laboratories Inc. Profile Avatar - Palmy Investing

Silicon Laboratories Inc.

Silicon Laboratories Inc., a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, and internationally. The company's products include wireless microcontrollers and sensor products. Its produ…
Semiconductors
US, Austin [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -41.38 -94.67 -66.96
Graham Fair Price -11.79 38.16 43.26
PEG 5251.90 1.06 0.02
Price/Book 12.90 3.93 3.49
Price/Cash Flow -78.38 -62.10 287.29
Prices/Earnings -34.41 -20.28 -15.09
Price/Sales -11.12 43.11 48.51
Price/FCF -78.38 -62.10 287.29
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -20.23 0.46 0.58
Operating Margin 33.97 -0.56 -0.84
ROA 13.04 -0.04 -0.05
ROE -0.06 -0.05 16.01
ROIC -0.04 -0.05 -12.61
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -1.00 0.00 -100.00
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -6.98 0.19 -97.26
EPS QOQ -7.64 0.19 -97.49
FCF QOQ 1.38 -6.04 337.00
Revenue QOQ -0.57 0.22 -60.81
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 476.38 310.86 -34.75
Days Sales Outstanding (DSO) 30.36 27.60 -9.10
Inventory Turnover 0.19 0.29 53.25
Debt/Capitalization 0.05 0.00 inf
Quick Ratio 2.86 3.28 14.53
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 37.95 36.53 -3.75
Cash 13.79 10.43 -24.40
Capex -0.12 -0.06 47.26
Free Cash Flow 0.46 -2.31 402.65
Revenue 2.73 3.33 22.25
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 4.51 5.80 28.61
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 3.03 4.13 36.03
Naive Interpretation Member
06 - Financial Health · Bad
End of SLAB's Analysis
CIK: 1038074 CUSIP: 826919102 ISIN: US8269191024 LEI: - UEI: -
Secondary Listings
SLAB has no secondary listings inside our databases.